Skip to main content
Medicover logo

Medicover — Investor Relations & Filings

Ticker · MCOV ISIN · SE0009778848 LEI · 5493000E9BUOYMOW2K53 ST Human health and social work activities
Open in API
Filings indexed 285 across all filing types
Latest filing 2022-09-14 Board/Management Inform…
Country SE Sweden
Listing ST MCOV

About Medicover

https://www.medicover.com/

Medicover is an international healthcare and diagnostic services provider. The company operates through two main divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division delivers a broad range of medical care, including primary care, specialist consultations, and hospital treatment. The Diagnostic Services division offers a comprehensive array of laboratory tests, from routine to advanced diagnostics, serving a wide network of clients. Committed to patient-centric care, Medicover focuses on quality, accessibility, and affordability by investing in modern medical technology and innovation. Its core mission is to improve and sustain the health and wellbeing of its customers.

Recent filings

Filing Released Lang Actions
Medicovers valberedning inför årsstämman 2023
Board/Management Information Classification · 1% confidence The document is a press release dated September 14, 2022, announcing the composition of the Nomination Committee (Valberedningen) for the upcoming Annual General Meeting (Årsstämman) in 2023. This committee is responsible for proposing board members and auditors for the AGM. While it relates to the AGM, the core content is the announcement of the committee's makeup and the deadline for shareholder proposals regarding the AGM. This falls under governance and preparatory materials for the AGM. Given the specific options, 'AGM-R' (AGM Information) is the most appropriate fit as it concerns materials and announcements related to the Annual General Meeting process, even though it's specifically about the nomination committee composition rather than the meeting presentation itself. It is not a DEF 14A (Remuneration) or a DVA (Voting Results).
2022-09-14 Swedish
Medicover’s nomination committee for the annual general meeting 2023
Board/Management Information Classification · 1% confidence The document is a press release dated September 14, 2022, announcing the composition of the Nomination Committee for the upcoming Annual General Meeting (AGM) in 2023. This information relates directly to the governance and preparation for the AGM, specifically concerning the process of nominating board members. While it is related to the AGM, it is not the AGM presentation itself (AGM-R) or the proxy materials (DEF 14A/PSI). It is a specific announcement regarding the governance structure leading up to the meeting. Given the options, this type of announcement about the committee responsible for nominations for the AGM fits best under Governance Information (CGR), as it details a key component of corporate governance structure related to board appointments. It is not a general regulatory filing (RNS) because a more specific category exists, and it is not a Director's Dealing (DIRS), Capital Change (CAP), or Earnings Release (ER).
2022-09-14 English
Earnings Release 2022
Earnings Release Classification · 1% confidence The document is titled "DELÅRSRAPPORT APRIL–JUNI 2022" (Interim Report April–June 2022) and contains detailed financial figures for the second quarter (Kv 2 2022) and the first six months (Första halvåret) of the year, including Net Sales, EBIT, Net Income, EBITDA, and EPS, presented in tables and narrative form. The content is comprehensive, covering performance analysis, segment breakdowns (Healthcare Services, Diagnostic Services), management commentary (VD-ORD), and forward-looking statements regarding financial goals. This structure and content strongly indicate a formal, periodic financial report covering a period shorter than a full year. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not an Annual Report (10-K) because it covers only Q2/H1, nor is it just an Earnings Release (ER) as it is a detailed report, not just highlights. Q2 2022
2022-07-22 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT APRIL–JUNE 2022' and contains comprehensive financial statements, including revenue, operating profit, EBITDA, and net profit for the second quarter and first half of the year. It also includes a CEO statement, detailed divisional performance analysis, and operational metrics. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q2 2022
2022-07-22 English
Antal aktier och röster i Medicover
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated April 29, 2022, titled "ANTAL AKTIER OCH RÖSTER I MEDICOVER" (Number of Shares and Votes in Medicover). It details a change in the total number of shares and the corresponding total voting rights following the conversion of A-shares to B-shares. This type of announcement, which reports on the current capital structure, specifically the total number of shares and votes outstanding, aligns best with announcements related to capital structure changes or significant share information. While it is not a formal 'Share Issue/Capital Change' (SHA) which usually implies a new issuance or split, it is a direct notification about the current state of the share capital and voting rights. Given the options, this specific notification about the total count of shares and votes, often required after corporate actions or periodically, fits closest to a general capital/financing update or a specific regulatory disclosure. Since it is a formal announcement detailing the exact count of shares and votes, it is a specific disclosure related to the company's capital structure. However, none of the codes perfectly match 'Total Share Count/Voting Rights Update'. Comparing the definitions, 'SHA' (Share Issue/Capital Change) is the closest category dealing with the structure of shares. Alternatively, since it is a mandatory disclosure of share structure changes, it could fall under 'RNS' (Regulatory Filings) as a general disclosure. Given the content focuses purely on the resulting share count and voting rights after internal conversions, it is a specific capital structure notification. I will classify it as 'SHA' as it directly relates to the composition of the share capital, even if it's not a new issuance, or 'RNS' as a general regulatory update. Since the document explicitly states the total number of shares and votes, which is a fundamental aspect of capital structure, SHA is slightly more specific than the general RNS fallback. However, looking closely at the definitions, SHA is for 'new share issues, stock splits, or other capital changes'. This is a report *after* a change. A more fitting category might be 'MRQ' (Major Shareholding Notification) if it involved crossing thresholds, but this is about the total count. Given the nature of mandatory disclosure regarding the total share count, and lacking a perfect fit, RNS (Regulatory Filings) is the safest fallback for specific, non-standard disclosures. But since it is about the share count, I will lean towards SHA as the most relevant topic area, recognizing it's an update on the existing structure rather than a new issuance. Re-evaluating: This is a mandatory disclosure of the total number of shares and votes, which is a key piece of information for shareholders. It is not a dividend (DIV), director dealing (DIRS), or management change (MANG). It is a specific regulatory disclosure. I will select RNS as the most appropriate general regulatory filing category when a specific capital structure update code is missing, as it is a mandatory public announcement. *Self-Correction based on common practice:* Announcements detailing the total number of shares and voting rights are often classified under general regulatory filings (RNS) or sometimes as a specific type of capital update. Given the options, RNS is the most robust choice for a mandatory press release detailing the current share/vote count that doesn't fit perfectly into SHA (new issue/split) or MRQ (major holder change).
2022-04-29 Swedish
Number of shares and votes in Medicover
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short press release dated April 29, 2022, announcing a change in the total number of shares and votes due to the conversion of Class A shares into Class B shares. This directly relates to changes in the company's capital structure (share classes and total votes). This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes to the capital structure, including share classes and total outstanding shares. It is not an earnings release (ER), a dividend notice (DIV), or a general regulatory filing (RNS), as it concerns a specific capital structure event.
2022-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.